DE60320826D1 - Verfahren zur diagnose von änderungen der darmabsorptionsoberfläche in einem individuum - Google Patents
Verfahren zur diagnose von änderungen der darmabsorptionsoberfläche in einem individuumInfo
- Publication number
- DE60320826D1 DE60320826D1 DE60320826T DE60320826T DE60320826D1 DE 60320826 D1 DE60320826 D1 DE 60320826D1 DE 60320826 T DE60320826 T DE 60320826T DE 60320826 T DE60320826 T DE 60320826T DE 60320826 D1 DE60320826 D1 DE 60320826D1
- Authority
- DE
- Germany
- Prior art keywords
- human
- apoa
- intestinal
- diagnosis
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000010521 absorption reaction Methods 0.000 title 1
- 101000806793 Homo sapiens Apolipoprotein A-IV Proteins 0.000 abstract 3
- 230000000968 intestinal effect Effects 0.000 abstract 2
- 108010071619 Apolipoproteins Proteins 0.000 abstract 1
- 102000007592 Apolipoproteins Human genes 0.000 abstract 1
- 206010003694 Atrophy Diseases 0.000 abstract 1
- 208000015943 Coeliac disease Diseases 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 238000012286 ELISA Assay Methods 0.000 abstract 1
- 206010059017 Intestinal mass Diseases 0.000 abstract 1
- 206010049416 Short-bowel syndrome Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000037444 atrophy Effects 0.000 abstract 1
- 238000001574 biopsy Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 208000019902 chronic diarrheal disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000001962 electrophoresis Methods 0.000 abstract 1
- 238000001839 endoscopy Methods 0.000 abstract 1
- 206010016766 flatulence Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 230000000951 immunodiffusion Effects 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 238000001262 western blot Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200201609A ES2217931B1 (es) | 2002-07-01 | 2002-07-01 | Metodo de diagnostico de la evolucion de la masa intestinal absortiva en un individuo. |
| PCT/ES2003/000323 WO2004003566A1 (es) | 2002-07-01 | 2003-06-30 | Método de diagnóstico de la evolución de la masa intestinal absortiva en un individuo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60320826D1 true DE60320826D1 (de) | 2008-06-19 |
Family
ID=29797410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60320826T Expired - Fee Related DE60320826D1 (de) | 2002-07-01 | 2003-06-30 | Verfahren zur diagnose von änderungen der darmabsorptionsoberfläche in einem individuum |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050214215A1 (de) |
| EP (1) | EP1560024B1 (de) |
| AT (1) | ATE394678T1 (de) |
| AU (1) | AU2003244659A1 (de) |
| DE (1) | DE60320826D1 (de) |
| ES (1) | ES2217931B1 (de) |
| WO (1) | WO2004003566A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT502227B1 (de) * | 2005-08-08 | 2007-08-15 | Vitateq Biotechnology Gmbh | Verfahren zur diagnose von tumoren |
| CA2632238A1 (en) * | 2005-12-01 | 2007-06-07 | Nps Pharmaceuticals, Inc. | A biomarker of improved intestinal function |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ319260A (en) * | 1995-09-15 | 1999-08-30 | Trinity College Dublin | Method for the diagnosis of coeliac disease |
| ES2126512B1 (es) * | 1997-03-10 | 1999-12-01 | Consejo Superior Investigacion | Peptido sintetico de la gamma-3 avenina para diagnostico y seguimiento de la enfermedad celiaca. |
| ES2182698B1 (es) * | 2001-05-14 | 2004-09-16 | Consejo Superior De Investigaciones Cientificas | Procedimiento para la extraccion cuantitativa de gluten en alimentos procesados o no procesados por calor, y composicion solubilizante de proteinas de gluten o un kit comercial que la contenga necesarios para su puesta en practica. |
| AU2002319613A1 (en) * | 2001-07-19 | 2003-03-03 | Signet Laboratories, Inc. | Human tissue specific drug screening procedure |
-
2002
- 2002-07-01 ES ES200201609A patent/ES2217931B1/es not_active Expired - Fee Related
-
2003
- 2003-06-30 EP EP03738136A patent/EP1560024B1/de not_active Expired - Lifetime
- 2003-06-30 DE DE60320826T patent/DE60320826D1/de not_active Expired - Fee Related
- 2003-06-30 US US10/519,318 patent/US20050214215A1/en not_active Abandoned
- 2003-06-30 AT AT03738136T patent/ATE394678T1/de not_active IP Right Cessation
- 2003-06-30 AU AU2003244659A patent/AU2003244659A1/en not_active Abandoned
- 2003-06-30 WO PCT/ES2003/000323 patent/WO2004003566A1/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP1560024A1 (de) | 2005-08-03 |
| ES2217931A1 (es) | 2004-11-01 |
| AU2003244659A1 (en) | 2004-01-19 |
| EP1560024B1 (de) | 2008-05-07 |
| WO2004003566A1 (es) | 2004-01-08 |
| ATE394678T1 (de) | 2008-05-15 |
| US20050214215A1 (en) | 2005-09-29 |
| ES2217931B1 (es) | 2006-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2427898C (en) | Method for differentiating between irritable bowel syndrome and inflammatory bowel disease using lactoferrin as marker | |
| US9880177B2 (en) | Fibrosis biomarker assay | |
| EP2799876A3 (de) | Klinische Diagnose von Leberfibrose mithilfe einer neuartigen Tafel mit Biomarkern mit einer geringen Menge menschlichem Plasmaprotein | |
| JP6402106B2 (ja) | Ｆｔ−ｉｃｒ−ｍｓ／ｍｓを使用した、歯肉炎および歯周炎のバイオマーカーのための唾液プロテオームの分析 | |
| Simsek et al. | Inflammatory mediators in the diagnosis and treatment of acute pancreatitis: pentraxin-3, procalcitonin and myeloperoxidase | |
| RU2009141523A (ru) | Биомаркеры для рассеянного склероза | |
| WO2004046729A3 (en) | Bodily fluid markers of tissue hypoxia | |
| DE60333608D1 (de) | Biomarker zur Diagnose von Alzheimer | |
| ATE328281T1 (de) | Methode zur diagnose von abnormalem knochenstoffwechsel | |
| ATE462001T1 (de) | Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit | |
| JP2010071900A (ja) | 新規非アルコール性脂肪性肝疾患バイオマーカーおよび該バイオマーカーを用いた非アルコール性脂肪性肝疾患の検出方法 | |
| DE60320826D1 (de) | Verfahren zur diagnose von änderungen der darmabsorptionsoberfläche in einem individuum | |
| Li et al. | Changes in lipid metabolism in patients with severe COVID-19 | |
| US8663944B2 (en) | Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions | |
| KR940005666A (ko) | C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법 | |
| Gaggar et al. | Biologic markers of mortality in acute lung injury | |
| Aotsuka et al. | A retrospective study of the fluctuation in serum levels of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis | |
| WO2002086447A3 (en) | Method for assessing risk for cardiac dysrhythmia in a human subject | |
| JP6158825B2 (ja) | テネイシンｃおよび関節リウマチにおけるその使用 | |
| Ali et al. | The role of chemerin and vaspin in Egyptian patients with viral hepatitis C | |
| RU2015133019A (ru) | Способ прогнозирования риска развития рака или диагностирования рака у индивидуума | |
| US20080241945A1 (en) | Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions | |
| Ragab et al. | Cartilage Oligomeric Matrix Protein As A Serological Biomarker for the Assessment of Liver Fibrosis Before and After Treatment of HCV Infection | |
| Takabatake et al. | Circulating levels of soluble Fas ligand in cachexic patients with COPD are higher than those in non-cachexic patients with COPD | |
| RU2195667C2 (ru) | Способ прогнозирования течения геморрагического инсульта |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8339 | Ceased/non-payment of the annual fee |